WELCOME TO
A fresh approach to Life Science PR & Marketing
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.
Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:
PR & Media
- Press releases
- Article writing and placement
- Media interviews
- Messaging
- Copy writing
- Social media
- Media training
Marketing
- Conference, event and trade show support
- Marketing literature
- Market research
- Campaign development
- Advertising
- Sponsorship
- Product launches
Design & Branding
- Website design and development
- Print collateral development
- Identity and logo creation
- Brand strategy
- Presentation development
- Video production
Investor Relations
- Business plan development
- Presentation development
- PR targeting the life science trade press read by investors
The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
BioTrinity 2024
-
ELRIG AI in Drug Discovery Forum
-
LSX World Congress 2024
-
EMBL- EBI Target to Patient
Zyme Communications expands UK head office with new facilities at Cambridge Innovation Park
Investment in new headquarters forms part of ongoing company growth plans and supports Zyme’s continued success, following client base and team expansion Cambridge, UK, 17 April 2024: Zyme Communications Ltd., [...]
Sphere Fluidics appoints Edward Rayner as Non-Executive Director
Ed Rayner joins Sphere Fluidics as new board member to strengthen the Company’s strategic vision and ambition for commercial growth Cambridge, UK, 17 April, 2024: Sphere Fluidics, a leading provider [...]
Bio-Rad Announces Collaboration Agreement with Oncocyte to Commercialize Transplant Monitoring with Droplet Digital PCR
Collaboration Aims to Provide Researchers Cutting-Edge Tools to Enable Transformational Monitoring of Key Biomarkers in Solid Tissue Transplants HERCULES, Calif.— April 12, 2024 — Bio-Rad Laboratories, Inc. (NYSE: BIO and [...]